The opioid epidemic is on the rise and requires action, but legitimate pain patients still need access to the medications they rely on. Abuse-deterrent formularies (ADFs) are opioid medications that are designed to resist physical and chemical extraction, making difficult for abusers to receive a “high.” Thus, ADFs help prevent addiction before it starts, without limiting access for legitimate pain patients.
Insurers don’t always cover ADFs, which makes them inaccessible and limits their potential in curbing opioid abuse.
Our position: Support
We believe ADFs represent a step forward in fighting the opioid epidemic without penalizing compliant patients, who may rely on opioids for pain management. Read our full position statement here.
ADFs represent a step forward in fighting the opioid epidemic without penalizing compliant patients.
Examples of U.S. Pain’s efforts
- Roundtable discusses benefits of abuse-deterrent formularies
- Advocating for safer medications at the FDA
- Why do we need abuse-deterrent formulations of opioid medications? – U.S. Pain
- FDA Facts: Abuse Deterrent Opioid Medications” – FDA
- Pain Scan: Abuse-Deterrent Technologies – Practical Pain Management
- Abuse-Deterrent Opioids: What You Need to Know – Medscape